Back
Editas Medicine Vs. Wayfair Industry Stock Comparison
Sell
5
EDIT
Editas Medicine
Last Price:
$1.19
Seasonality Move:
-2.49%
Sell
20
W
Wayfair
Last Price:
$33.90
Seasonality Move:
45.65%
Sell
5
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.13. The Score for EDIT is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
W Stock Price Chart
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 38.21 | Sell |
Chaikin Money Flow: | -1418416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 1.78) | Sell |
Bollinger Bands (100): | (1.15 - 2.35) | Sell |
W Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.89 | Sell |
Relative Strength Index (14 RSI): | 39.38 | Sell |
Chaikin Money Flow: | -2404271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.46 - 38.4) | Sell |
Bollinger Bands (100): | (36.99 - 49.17) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Sell |
20-day SMA: | 1.44 | Sell |
50-day SMA: | 1.48 | Sell |
200-day SMA: | 2.98 | Sell |
8-day EMA: | 1.1 | Buy |
20-day EMA: | 0.75 | Buy |
50-day EMA: | 0.38 | Buy |
200-day EMA: | 0.11 | Buy |
W Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.07 | Sell |
20-day SMA: | 33.61 | Sell |
50-day SMA: | 40.94 | Sell |
200-day SMA: | 46.24 | Sell |
8-day EMA: | 33.84 | Sell |
20-day EMA: | 35.17 | Sell |
50-day EMA: | 38.96 | Sell |
200-day EMA: | 45.97 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Wayfair Earnings Growth & W Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.13 per share, and an increase next year of $0.89 per share.
Editas Medicine Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Wayfair Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |